According to a recent report by 9amHealth, GLP-1 medications have become one of the top three benefits in the workplace. The survey conducted by the organization revealed that these medications have transitioned from being a trend to a common expectation among employees. Despite their increasing popularity, the primary barrier to access remains the cost associated with these medications. The survey indicated that a significant share of respondents identified cost as the number one obstacle to obtaining GLP-1 medications. This shift in perception highlights the growing importance of these medications in the workplace, with a notable number of respondents recognizing their value.